Embecta Corp. (NASDAQ:EMBC) Shares Acquired by Allianz Asset Management GmbH

Allianz Asset Management GmbH lifted its position in shares of Embecta Corp. (NASDAQ:EMBCFree Report) by 77.0% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 141,124 shares of the company’s stock after buying an additional 61,400 shares during the period. Allianz Asset Management GmbH owned 0.25% of Embecta worth $2,671,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of EMBC. Public Employees Retirement System of Ohio boosted its holdings in shares of Embecta by 66.2% during the third quarter. Public Employees Retirement System of Ohio now owns 2,284 shares of the company’s stock worth $34,000 after purchasing an additional 910 shares during the last quarter. Bfsg LLC purchased a new position in Embecta during the fourth quarter worth about $53,000. PEAK6 Investments LLC acquired a new stake in Embecta in the 3rd quarter worth about $219,000. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Embecta by 29.4% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,003 shares of the company’s stock valued at $284,000 after buying an additional 3,411 shares during the period. Finally, Algert Global LLC increased its stake in shares of Embecta by 102.5% during the 3rd quarter. Algert Global LLC now owns 22,130 shares of the company’s stock valued at $333,000 after acquiring an additional 11,200 shares during the last quarter. Institutional investors and hedge funds own 93.83% of the company’s stock.

Embecta Stock Down 2.9 %

Shares of NASDAQ EMBC opened at $12.44 on Friday. The stock has a market capitalization of $717.41 million, a PE ratio of 10.28 and a beta of 0.99. The firm has a fifty day moving average of $12.06 and a 200-day moving average of $14.81. Embecta Corp. has a 52-week low of $9.93 and a 52-week high of $28.00.

Embecta (NASDAQ:EMBCGet Free Report) last posted its quarterly earnings results on Thursday, May 9th. The company reported $0.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.24. The firm had revenue of $287.20 million during the quarter, compared to the consensus estimate of $264.70 million. Embecta had a negative return on equity of 18.42% and a net margin of 6.20%. The firm’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.75 earnings per share. Equities research analysts expect that Embecta Corp. will post 2.3 EPS for the current fiscal year.

Embecta Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 14th. Investors of record on Tuesday, May 28th will be issued a $0.15 dividend. The ex-dividend date of this dividend is Friday, May 24th. This represents a $0.60 annualized dividend and a yield of 4.82%. Embecta’s payout ratio is 49.59%.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley cut their price objective on shares of Embecta from $16.00 to $13.00 and set an “underweight” rating on the stock in a report on Friday, May 10th.

Read Our Latest Stock Report on EMBC

About Embecta

(Free Report)

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.

Featured Stories

Institutional Ownership by Quarter for Embecta (NASDAQ:EMBC)

Receive News & Ratings for Embecta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embecta and related companies with MarketBeat.com's FREE daily email newsletter.